Trial Profile
The influence of irbesartan on biomarkers of renal function and oxidative stress
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Biomarker; Pharmacodynamics
- 10 Mar 2014 New trial record